Andrew Sinclair
Director at Adicet Bio, Inc. (ACET) since March 2021
Andrew Sinclair has filed 25 insider reports with the SEC since March 2021, as director at Adicet Bio, Inc. (ACET), director at Soleno Therapeutics Inc (SLNO) and director at Sierra Oncology, Inc. (SRRA) and at 1 more company. Andrew Sinclair made no open-market purchases or sales in the last 12 months. The latest filing, on June 23, 2026, reports grant or award at Adicet Bio, Inc. (ACET).
- Filings
- 25
- Companies
- 4
- Bought on market
- $18.1M
- Sold on market
- None
Companies where Andrew Sinclair is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince March 2021 | 17,700 | $14M | $14.00 | $2.78-80% | Jun 23, 2026 | ||
| Director | 0 | May 18, 2026 | |||||
| Director | $4.05M | $27.00 | Jul 1, 2022 | ||||
| Director | Aug 10, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Jun 21, 2026ACETSEC Form 4 filed by Director Sinclair AndrewForm 4Grant or award
- May 18, 2026SLNODirector Sinclair Andrew returned 10,491 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- Jun 11, 2025ACETDirector Sinclair Andrew was granted 5,900 shares, increasing direct ownership by 50% to 17,700 unitsForm 4Grant or award
- Jun 5, 2025SLNODirector Sinclair Andrew was granted 3,991 shares, increasing direct ownership by 61% to 10,491 unitsForm 4Grant or award
- Aug 21, 2024ACETSEC Form 4 filed by Director Sinclair AndrewForm 4Grant or awardSale back to the company
- Jun 6, 2024SLNODirector Sinclair Andrew was granted 6,500 sharesForm 4Grant or award
- Jun 5, 2024ACETSinclair Andrew was granted 5,900 shares, increasing direct ownership by 100% to 11,800 unitsForm 4Grant or award
- Aug 14, 2023ACETSEC Form 4 filed by Sinclair AndrewForm 4Grant or awardSale back to the company
- Jun 1, 2023ACETSEC Form 4 filed by Sinclair AndrewForm 4Grant or award
- May 26, 2023SLNOSEC Form 4 filed by Sinclair AndrewForm 4Grant or award
- Oct 14, 2022SLNOSEC Form 4 filed by Sinclair AndrewForm 4
- Jun 1, 2022SLNOSEC Form 4 filed by Sinclair AndrewForm 4Grant or award
- Jul 1, 2022SRRASEC Form 4: Sinclair Andrew returned $72,276,985 worth of shares to the company (1,314,127 units at $55.00) (withholding obligation)Form 4Sale back to the company
- Jun 2, 2022ACETSEC Form 4 filed by Sinclair AndrewForm 4Grant or award
- Mar 29, 2022SLNOSEC Form 4: Sinclair Andrew bought 7,720,000 sharesForm 4Open-market purchase
- Jan 31, 2022+$4.05MSRRASEC Form 4: Sinclair Andrew bought $4,050,000 worth of shares (150,000 units at $27.00) and exercised 287,471 in-the-money shares at a strike of $13.20Form 4Open-market purchaseExercise of an in-the-money derivative
- Dec 8, 2021+$7MACETSEC Form 4: Sinclair Andrew bought $7,000,000 worth of shares (500,000 units at $14.00) (Amendment)Form 4Open-market purchase
- Dec 8, 2021+$7MACETSEC Form 4: Sinclair Andrew bought $7,000,000 worth of shares (500,000 units at $14.00)Form 4Open-market purchase
- Aug 9, 2021VRNASEC Form 4 filed by Sinclair AndrewForm 4Grant or award
- Jun 1, 2021SLNOSEC Form 4 filed by Sinclair AndrewForm 4Grant or award
- Apr 30, 2021ACETSEC Form 4 filed by Sinclair AndrewForm 4Grant or award
- Mar 2, 2021ACETSEC Form 4 filed by Andrew SinclairForm 4Grant or award
- Mar 2, 2021ACETSEC Form 3: Andrew Sinclair claimed ownership of 1,615,385 units of Common StockForm 3New insider
- Mar 2, 2021ACETSEC Form 4 filed by Andrew SinclairForm 4Grant or award
- Mar 2, 2021ACETSEC Form 3: Andrew Sinclair claimed ownership of 1,640,721 units of Common StockForm 3New insider
Also sits on boards with
Officers and directors who share two or more companies with Andrew Sinclair.
Compare Andrew Sinclair with
- Andrew Sinclair vs Kevin Norrett2 shared
- Andrew Sinclair vs Mark W Hahn2 shared
- Andrew Sinclair vs LLP Abingworth2 shared
- Andrew Sinclair vs Lloyd Klickstein1 shared
- Andrew Sinclair vs Chen Schor1 shared
- Andrew Sinclair vs Blake Aftab1 shared
Other insiders at the same companies
- Lloyd KlicksteinACET
- Chen SchorACET
- Blake AftabACET
- Steve DubinACET
- Jeffrey ChodakewitzACET
- Michael GrissingerACET
- Katie PengACET
- Kristen YenSLNO
- Birgitte VolckSLNO
- Matthew PaulsSLNO
- Meredith ManningSLNO
- Manher JoshiSLNO
- Michael F. HuangSLNO
- Patricia C HiranoSLNO
Questions about Andrew Sinclair
- What is Andrew Sinclair's role at Adicet Bio, Inc.?
- Andrew Sinclair reports to the SEC as director at Adicet Bio, Inc. (ACET), according to the latest filing on June 23, 2026. Andrew Sinclair has also filed as director at Soleno Therapeutics Inc (SLNO), director at Sierra Oncology, Inc. (SRRA) and director at Verona Pharma plc (VRNA).
- How many shares does Andrew Sinclair own?
- After the latest filing that states it, Andrew Sinclair directly owned 17,700 shares of Adicet Bio, Inc. (ACET). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Andrew Sinclair bought or sold stock recently?
- The most recent open-market purchase was on January 31, 2022: bought 150,000 shares of Sierra Oncology, Inc. (SRRA) for $4.05M at an average of $27.00.
- How do I get alerts when Andrew Sinclair files?
- Follow Andrew Sinclair on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Andrew Sinclair (SEC CIK 0001762451). Totals count each trade once, skipping amendments whose original is on file, from Mar 4, 2021 on. View on SEC EDGAR